126 related articles for article (PubMed ID: 8763262)
21. Expression of CD44H and CD44v3 in normal oesophagus, Barrett mucosa and oesophageal carcinoma.
Castellà E; Ariza A; Fernández-Vasalo A; Roca X; Ojanguren I
J Clin Pathol; 1996 Jun; 49(6):489-92. PubMed ID: 8763264
[TBL] [Abstract][Full Text] [Related]
22. The recognition of cancer-associated fucosylated antigens in colorectal cancer by a novel monoclonal antibody, YB-2.
Naitoh H; Yazawa S; Asao T; Nakajima T; Nakamura J; Takenoshita S; Nagamachi Y
Surg Today; 1994; 24(4):382-4. PubMed ID: 8038519
[TBL] [Abstract][Full Text] [Related]
23. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of a putative adenoma-associated antigen in pre-colonoscopic effluent of patients with colorectal cancer.
Tobi M; Darmon E; Phillips T; Heller T; Rozen P; Nochomovitz L; Steinberg W
Cancer Lett; 1990 May; 51(1):21-5. PubMed ID: 2337894
[TBL] [Abstract][Full Text] [Related]
25. Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and
Hartmans E; Orian-Rousseau V; Matzke-Ogi A; Karrenbeld A; de Groot DJ; de Jong S; van Dam GM; Fehrmann RS; Nagengast WB
Theranostics; 2017; 7(2):482-492. PubMed ID: 28255344
[TBL] [Abstract][Full Text] [Related]
26. CD44 in colon cancer.
Herrlich P; Pals S; Ponta H
Eur J Cancer; 1995; 31A(7-8):1110-2. PubMed ID: 7577002
[TBL] [Abstract][Full Text] [Related]
27. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.
Gotley DC; Fawcett J; Walsh MD; Reeder JA; Simmons DL; Antalis TM
Br J Cancer; 1996 Aug; 74(3):342-51. PubMed ID: 8695347
[TBL] [Abstract][Full Text] [Related]
28. CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells.
Abbasi AM; Chester KA; Talbot IC; Macpherson AS; Boxer G; Forbes A; Malcolm AD; Begent RH
Eur J Cancer; 1993; 29A(14):1995-2002. PubMed ID: 8280495
[TBL] [Abstract][Full Text] [Related]
29. CD44 splice variant expression in clear cell carcinoma of the ovary.
Rodríguez-Rodríguez L; Sancho-Torres I; Leakey P; Gibbon DG; Comerci JT; Ludlow JW; Mesonero C
Gynecol Oncol; 1998 Nov; 71(2):223-9. PubMed ID: 9826464
[TBL] [Abstract][Full Text] [Related]
30. Expression of alpha-3/4-monofucosylated polylactosaminoglycan epitope, as defined by monoclonal antibody FW6, is a marker of the colorectal adenoma-carcinoma sequence.
Baldus SE; Vierbuchen M; Hanisch FG; Schwonzen M; Fischer R
Cancer; 1995 Sep; 76(6):954-60. PubMed ID: 8625220
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical localization of the epithelial marker MAM-6 in invasive malignancies and highly dysplastic adenomas of the large intestine.
Zotter S; Lossnitzer A; Hageman PC; Delemarre JF; Hilkens J; Hilgers J
Lab Invest; 1987 Aug; 57(2):193-9. PubMed ID: 3613527
[TBL] [Abstract][Full Text] [Related]
32. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.
Heider KH; Hofmann M; Hors E; van den Berg F; Ponta H; Herrlich P; Pals ST
J Cell Biol; 1993 Jan; 120(1):227-33. PubMed ID: 8416989
[TBL] [Abstract][Full Text] [Related]
33. [Expression of tumor-associated antigen LEA and its significance for pathological diagnosis].
Feng H; Song JD
Ai Zheng; 2002 Jun; 21(6):658-62. PubMed ID: 12452070
[TBL] [Abstract][Full Text] [Related]
34. Positive relationship between expression of CD44 and hepatic metastases in colorectal cancer.
Ichikawa W
Pathobiology; 1994; 62(4):172-9. PubMed ID: 7537507
[TBL] [Abstract][Full Text] [Related]
35. Different CD44 splicing patterns define prognostic subgroups in multiple myeloma.
Stauder R; Van Driel M; Schwärzler C; Thaler J; Lokhorst HM; Kreuser ED; Bloem AC; Günthert U; Eisterer W
Blood; 1996 Oct; 88(8):3101-8. PubMed ID: 8874209
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical localization of epithelial glycoprotein EGP-2 and carcinoembryonic antigen in normal colonic mucosa and colorectal tumors.
Ogura E; Senzaki H; Yoshizawa K; Hioki K; Tsubura A
Anticancer Res; 1998; 18(5B):3669-75. PubMed ID: 9854475
[TBL] [Abstract][Full Text] [Related]
37. CD44 as a marker in human cancers.
Sy MS; Mori H; Liu D
Curr Opin Oncol; 1997 Jan; 9(1):108-12. PubMed ID: 9090502
[TBL] [Abstract][Full Text] [Related]
38. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
[TBL] [Abstract][Full Text] [Related]
39. Are CD44 variant isoforms involved in human tumour progression?
Günthert U; Stauder R; Mayer B; Terpe HJ; Finke L; Friedrichs K
Cancer Surv; 1995; 24():19-42. PubMed ID: 7553660
[TBL] [Abstract][Full Text] [Related]
40. Expression of proliferating cell nuclear antigen and CD44 variant exon 6 in primary tumors and corresponding lymph node metastases of colorectal carcinoma with Dukes' stage C or D.
Zhang JC; Wang ZR; Cheng YJ; Yang DZ; Shi JS; Liang AL; Liu NN; Wang XM
World J Gastroenterol; 2003 Jul; 9(7):1482-6. PubMed ID: 12854146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
